65--Notice of intent to award a purchase order under authority of FAR 6.302-1 for stability testing of PBT vaccine product.

The contract anticipates awarding a sole source, Firm Fixed Price Purchase Order under FAR 6.302-1 authority for the annual testing and evaluation of the stability of the Investigational New Drug Pentavalent Botulinum Toxoid (PBT) vaccine for fiscal year 2011. This procurement concerns the remaining single lot of the PBT vaccine produced by Emergent BioSolutions, who has been the exclusive provider of the required testing services. The notice clarifies that this is not a request for competitive proposals, but parties capable of performing the work under current Good Laboratory Practice (cGLP) standards and possessing the necessary qualifications are invited to provide official documentation within 10 days. The contract is managed by the Department of Defense through the W6QK Acc-apg Natick office located in Natick, Massachusetts. The relevant solicitation number is W911QY-11-P-0434, and all inquiries or submissions must be directed in writing to Contracting Officer Sandra O’Connell via mail, email, or fax. The service required involves stability testing under strict regulatory standards to ensure the vaccine's efficacy and safety, reflecting the specialized and critical nature of the procurement.